| 536 |
increased |
|
liposarcoma
(MESH:D008080)
|
1036: Increased, liposarcoma
|
| 537 |
increased |
|
hemangiosarcoma
(MESH:D006394)
|
1037: Increased, hemagiosarcoma
|
| 538 |
increased |
beta-2 adrenergic receptor binding
(GO:0031698)
|
beta-2 adrenergic receptor
(PR:000001193)
|
1038: Activation, beta-2 adrenergic receptor
|
| 539 |
increased |
beta2-adrenergic receptor activity
(GO:0004941)
|
beta-2 adrenergic receptor
(PR:000001193)
|
1039: Increased activity, beta-2 adrenergic receptor
|
| 540 |
increased |
relaxation of smooth muscle
(GO:0044557)
|
|
1040: relaxation, smooth muscle
|
| 541 |
increased |
cell proliferation
(GO:0008283)
|
smooth muscle cell
(CL:0000192)
|
1042: Proliferation/Clonal Expansion, smooth muscle
|
| 542 |
increased |
hypertrophy
(MESH:D006984)
|
smooth muscle tissue
(UBERON:0001135)
|
1043: Hypertrophy/hyperplasia, smooth muscle
|
| 543 |
increased |
|
leiomyoma
(MESH:D007889)
|
1044: Promotion, mesovarian leiomyomas
|
| 546 |
increased |
hyperplasia
(MESH:D006965)
|
stromal cell of ovary
(CL:0002132)
|
1051: Hyperplasia, ovarian stromal cells
|
| 547 |
increased |
hyperplasia
(MESH:D006965)
|
epithelium of female gonad
(UBERON:0004911)
|
1052: Hyperplasia, ovarian epithelium
|
| 548 |
increased |
|
Granular Cell Tumor
(MESH:D016586)
|
1054: Promotion, ovarian granular cell tumors
|
| 551 |
increased |
|
cholecystokinin
(PR:000005110)
|
1061: prolonged, elevation of serun CCK
|
| 552 |
increased |
cell proliferation
(GO:0008283)
|
acinar cell
(CL:0000622)
|
1062: Increased, Cellular proliferation / hyperplasia of acinar cells
|
| 553 |
increased |
intracellular estrogen receptor signaling pathway
(GO:0030520)
|
estrogen receptor alpha complex
(PR:000027727)
|
1065: Activation, estrogen receptor alpha
|
| 554 |
increased |
gene expression
(GO:0010467)
|
homeobox protein SIX1
(PR:000014896)
|
2329: Sine oculis homeobox 1 gene expression, increased
|
| 555 |
increased |
cell proliferation
(GO:0008283)
|
basal cell
(CL:0000646)
|
1067: Proliferation/Clonal Expansion, aberrant basal-type cells
|
| 557 |
increased |
hyperplasia
(MESH:D006965)
|
glandular epithelial cell
(CL:0000150)
|
2 Events
|
| 558 |
increased |
|
adenosquamous carcinoma
(MESH:D018196)
|
1070: Increased, adenosquamous carcinomas of endometrium
|
| 561 |
increased |
|
estrogen
(CHEBI:50114)
|
1076: Increased, circulating estrogen levels
|
| 562 |
increased |
|
prolactin
(PR:000013246)
|
1077: Increased, prolactin exposure
|
| 563 |
increased |
mammary gland hyperplasia
(MP:0000630)
|
|
1078: Hyperplasia, Mammary gland
|
| 564 |
increased |
abnormal tumor latency
(MP:0010307)
|
|
1080: Increased, latency period
|
| 565 |
increased |
hyperplasia
(MESH:D006965)
|
prolactin secreting cell
(CL:0000439)
|
1081: Increased, lactotroph hyperplasia and hypertrophy
|
| 566 |
increased |
hypertrophy
(MESH:D006984)
|
prolactin secreting cell
(CL:0000439)
|
1081: Increased, lactotroph hyperplasia and hypertrophy
|
| 567 |
increased |
Pituitary adenoma
(HP:0002893)
|
Adenoma
(MESH:D000236)
|
1082: Increased, adenomas (pituitary)
|